α-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy

International Journal of Cancer

Volumn 104, Issue 2, 2003, Pages 243-250

  Leonetti, Carlo ^a   Biroccio, Annamaria ^a   Gabellini, Chiara ^a   Scarsella, Marco ^a   Maresca, Vittoria ^b   Flori, Enrica ^b   Bove, Loredana ^c   Pace, Andrea ^a   Stopacciaro, Antonella ^d   Zupi, Gabriella ^a   Cognetti, Francesco ^a   Picardo, Mauro ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^c SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^d Pathology Department II   (Italy)

Author keywords

Antineoplastic drug; Antioxidant; Chemoprotection; Combination treatment; Neuropathy

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; CISPLATIN; POLYUNSATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; DEATH; ENZYME ACTIVITY; HISTOLOGY; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NERVE; PRIORITY JOURNAL; TUMOR GROWTH;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL DIVISION; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPID PEROXIDATION; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NERVOUS SYSTEM; NEUROPROTECTIVE AGENTS; SURVIVAL RATE; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0037457391     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10933     Document Type: Article

References (30)

1. McKeage MJ. Clinical toxicology of platinum-based cancer chemotherapeutic agents. In: Kelland LR, Farrell N, eds. Platinum-based drugs in cancer therapy. Totowa NJ: Humana Press, 2000. 251-75.
2. Hensley ML, Schuchter LM, Lindley C, Meropol NJ, Cohen GI, Broder G, Gradishar WJ, Green DM, Langdon RJ Jr., Mitchell RB, Negrin R, Szatrowski TP, et al. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants. J Clin Oncol 1999;7:3333-55.
3. Rick O, Beyer J, Schwella N, Schubart H, Schleicher J, Siegert W. Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor. Ann Oncol 2001;12:1151-5.
4. Gradishar WJ, Stephenson P, Glover DJ, Neuberg DS, Moore MR, Windschitl HE, Piel I, Abeloff MD. A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group study (E8188). Cancer 2001;92:2517-22.
5. McCarron MO, Russell AJ, Metcalfe RA, Deysilva R. Chronic vitamin E deficiency causing spinocerebellar degeneration, peripheral neuropathy, and centro-cecal scotomata. Nutrition 1999;15:217-9.
6. Bove L, Picardo M, Maresca V, Jandolo B, Pace A. A pilot study on the relation between cisplatin neuropathy and vitamin E. J Exp Clin Cancer Res 2001;20:277-80.
7. Rao MV, Sharma PS. Protective effect of vitamin E against mercuric chloride reproductive toxicity in male mice. Reprod Toxicol 2001; 15: 705-12.
8. Mileva M, Bakalov R, Tancheva L, Galabov A, Ribarov S. Effect of vitamin E supplementation on lipid peroxidation in blood and lung of influenza virus infected mice. Comp Immunol Microbiol Infect Dis 2002;25:1-11.
9. Post A, Rucker M, Ohl F, Uhr M, Holsboer F, Almeida OF, Michaelidis TM. Mechanisms underlying the protective potential of alphatocopherol (vitamin E) against haloperidol-associated neurotoxicity. Neuropsychopharmacology 2002;26:397-407.
10. Sigounas G, Anagnostou A, Steiner M. dl-Alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 1997;28:30-5.
11. Weber T, Lu M, Andera L, Lahm H, Gellert N, Fariss MW, Korinek V, Sattler W, Ucker DS, Terman A, Schroder A, Erl W, et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res 2002;8:863-9.
12. Yam D, Peled A, Shinitzky M. Suppression of tumor growth and metastasis by dietary fish oil combined with vitamins E and C and cisplatin. Cancer Chemother Pharmacol 2001;47:34-40.
13. Sarna S, Kumar A, Bhola RK. Alpha-tocopherol enhances tumour growth inhibition by cis-dichlorodiammine platinum (II). Braz J Med Biol Res 2000;33:929-36.
14. Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-alpha 2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer 1994;2:233-45.
15. Geran RI, Greenberg NH, Macdonald MM, Shumacher AM, Abbott BJ. Protocols for screening chemical agents and natural products against animal tumors and other biological systems, ed. 3. Cancer Chemother Rep 1972;3:1-88.
16. Burton GW, Webb A, Ingold KU. A mild. rapid and efficient method of lipid extraction for use in determining vit. E/lipid ratios. Lipids 1985;20:29-39.
17. Picardo M, Grammatico P, Roccella F, Roccella M, Grandinetti M, Del Porto G, Passi S. Imbalance in the antioxidant pool in melanoma cells and normal melanocytes from patients with melanoma. J Invest Dermatol 1996;107:322-6.
18. Clairborne A. Catalase activity. In: Greenwald RA, ed. Handbook of methods for oxygen radical research. Boca Raton, FL: CRC, 1985. 283-4.
19. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 1996;20:251-6.
20. Passi S, Morrone A, Picardo M, De Luca C, Ippolito F. Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides and glutathione peroxidase in patients with seborrheic dermatitis. J Dermatol Sci 1991;2:171-8.
21. Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol Pharmacol 2001;60:174-82.
22. Chu G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 1994;269:787-90.
23. Senturker S, Tschirret-Guth R, Morrow J, Levine R, Shacter E. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species. Arch Biochem Biophys 2002;397:262-72.
24. Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000;93:163-70.
25. Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, Djuric Z. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds. Cancer Res 1994;54:3346-51.
26. Airriess G, Changehit C, Chen LC, Chow CK. Increased levels of vitamin E in the lung of guinea pigs exposed to mainstream or sidestream smoke. Nutr Res 1988;8:653-61.
27. Chow CK. Cigarette smoking and oxidative damage in the lung. Ann NY Acad Sci 1993;686:289-98.
28. Chow CK. Vitamin E and oxidative stress. Free Radic Biol Med 1991;11:215-32.
29. Park SA, Choi KS, Bang JH, Huh K, Kim SU. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand. J Neurochem 2000;75:946-53.
30. Muller DP, Lloyd JK, Wolff OH. Vitamin E and neurological function. Lancet 1983;1:225-8.